Sales & Marketing News | pharmaphorum

News

FDA has turned down Sanofi's oral BTK inhibitor tolebrutinib for multiple sclerosis, despite suggesting earlier it would delay a decision until 2026.

News

More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time.

News

CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.

News

Sanofi's last job before breaking up for the Christmas holiday? Putting the finishing touches on a $2.5bn agreement to buy vaccine firm Dynavax.

News

CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.

News

The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of its Wegovy pill.